PREVALENCE OF BILATERAL TESTICULAR GERM-CELL TUMORS AND EARLY DETECTION BASED ON CONTRALATERAL TESTICULAR INTRAEPITHELIAL NEOPLASIA

被引:58
作者
DIECKMANN, KP
LOY, V
BUTTNER, P
机构
[1] FREE UNIV BERLIN,KLINIKUM STEGLITZ,INST PATHOL,W-1000 BERLIN 45,GERMANY
[2] FREE UNIV BERLIN,KLINIKUM STEGLITZ,INST MED STAT,W-1000 BERLIN 45,GERMANY
来源
BRITISH JOURNAL OF UROLOGY | 1993年 / 71卷 / 03期
关键词
D O I
10.1111/j.1464-410X.1993.tb15955.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The prevalence ot bilateral tumours was found to be 4% in a retrospective analysis of 531 consecutive patients with testicular germ cell tumours. Patients with bilateral tumours were younger when their first tumour was diagnosed than those who had only 1 testicular tumour. Bilateral undescended testis was more frequent in 21 patients with bilateral tumours than in the total population of patients examined (2 of 21 versus 10 of 452, i.e. 9.5% versus 2.2%). Histology and unilateral undescended testis were not helpful in identifying patients at risk of developing a second tumour. In a separate study, 76 consecutive patients with unilateral testicular cancer underwent contralateral testicular biopsy at the time of orchiectomy. Five patients had testicular intra-epithelial neoplasia (TIN, so-called carcinoma in situ) in the contralateral testis; 1 of these patients had a history of bilateral undescended testis and 4 had an increased level of serum follicle stimulating hormone post-operatively. None of the other 71 patients had developed a second tumour after a median observation time of 30 months. Testicular biopsy and a search for TIN appear to be a safe method for the early identification of the patients at risk of developing a contralateral testicular tumour.
引用
收藏
页码:340 / 345
页数:6
相关论文
共 41 条
  • [11] ERPENBACH K, 1990, UROLOGE A, V29, P102
  • [12] MANAGEMENT OF THE CONTRALATERAL TESTIS IN PATIENTS WITH TESTICULAR GERM-CELL CANCER
    FORDHAM, MVP
    MASON, MD
    BLACKMORE, C
    HENDRY, WF
    HORWICH, A
    [J]. BRITISH JOURNAL OF UROLOGY, 1990, 65 (03): : 290 - 293
  • [13] CISPLATIN-BASED CHEMOTHERAPY DOES NOT ELIMINATE THE RISK OF A 2ND TESTICULAR CANCER
    FOSSA, SD
    AASS, N
    [J]. BRITISH JOURNAL OF UROLOGY, 1989, 63 (05): : 531 - 534
  • [14] PREVALENCE OF CARCINOMA INSITU AND OTHER HISTOPATHOLOGICAL ABNORMALITIES IN TESTES OF MEN WITH A HISTORY OF CRYPTORCHIDISM
    GIWERCMAN, A
    BRUUN, E
    FRIMODTMOLLER, C
    SKAKKEBAEK, NE
    [J]. JOURNAL OF UROLOGY, 1989, 142 (04) : 998 - 1002
  • [15] HARTUNG R, 1983, VERH DTSCH GES UROL, V34, P406
  • [16] BILATERAL PRIMARY GERM-CELL TUMORS OF TESTIS
    HOEKSTRA, HJ
    WOBBES, T
    SLEYFER, T
    KOOPS, HS
    [J]. UROLOGY, 1982, 19 (02) : 152 - 154
  • [17] CURRENT CONTROVERSIES IN THE MANAGEMENT OF TESTICULAR CANCER
    HORWICH, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (03) : 322 - 326
  • [18] KLEINSCHMIDT K, 1989, UROLOGE A, V28, P281
  • [19] BILATERAL MALIGNANT TESTICULAR GERM-CELL CANCER
    KRISTIANSLUND, S
    FOSSA, SD
    KJELLEVOLD, K
    [J]. BRITISH JOURNAL OF UROLOGY, 1986, 58 (01): : 60 - 63
  • [20] KRUSE C, 1987, UROLOGE A, V26, P61